Preoperative coagulation-inflammation-nutrition profiling for postoperative ICU admission after gastrointestinal tumor surgery

Every year, millions of people undergo surgery to remove tumors from their digestive systems. While modern medicine has made these operations safer than ever, the journey does not end when the surgeon closes the incision. For some patients, the recovery is straightforward, allowing them to return to a standard hospital ward. For others, the body struggles to cope with the stress of the operation, requiring a transfer to an intensive care unit for closer monitoring and life-support equipment. Predicting who will need this higher level of care is a critical challenge for doctors. It helps them prepare hospital resources, plan for the patient's needs, and have honest conversations with families before the surgery begins. Traditionally, doctors have relied on broad factors like a patient's age, existing health conditions, and the complexity of the operation to make these guesses. However, these standard tools often miss the subtle, internal signals of how a specific person's body is currently functioning.

A team of researchers at Guangxi Medical University set out to find a better way to see these internal signals. They focused on three specific biological markers that are routinely measured in blood tests before surgery: a protein that helps blood clot, a protein that indicates inflammation, and a protein that reflects nutritional health. The idea is that when a body is under stress or fighting an illness, these levels shift in predictable ways. By combining these three numbers into a single, simple score, the researchers hoped to create a clearer picture of a patient's resilience. They wanted to know if this "biological snapshot" could predict who would need intensive care after gastrointestinal tumor surgery better than the standard methods used today.

The researchers analyzed data from nearly 4,800 adults who had undergone non-emergency surgery for tumors in the stomach, intestines, liver, or pancreas. They looked at blood samples taken just before the operation to measure albumin, fibrinogen, and C-reactive protein. They assigned points based on whether these levels were abnormal: one point for low albumin, one for high fibrinogen, and one for high C-reactive protein. This created a simple score ranging from zero to three. A score of zero meant all three markers were within a healthy range, while a score of three indicated that all three were abnormal. The team then tracked how many of these patients ended up in the intensive care unit after their surgery.

The results showed a clear and steady pattern. Patients with a score of zero had a relatively low chance of needing intensive care, with only about 8.7 percent requiring admission. As the score increased, the risk rose sharply. Those with a score of one saw their risk jump to 17.5 percent, those with a score of two faced a 21.9 percent chance, and patients with the highest score of three had a 26.7 percent likelihood of needing intensive care. Even after the researchers adjusted for other known risk factors like age, body weight, and the type of surgery performed, the score remained a powerful predictor. Each additional point on the scale was associated with a significantly higher odds of requiring intensive care. This suggests that the combination of poor nutrition, active inflammation, and blood clotting issues creates a specific biological state that makes recovery more difficult, regardless of the patient's age or the surgeon's skill.

To ensure this new score was truly useful, the team compared it against other methods doctors might use. They tested it against a simpler ratio that only looked at two of the markers, and they also tested it against much more complex formulas that included additional blood cell counts and immune system data. The study found that the simple three-part score performed better than the two-marker ratio. More importantly, adding more complex data did not improve the prediction. The complicated formulas that tried to include extra immune markers did not outperform the straightforward three-marker score. This is a significant finding because it suggests that doctors do not need to wait for a long list of specialized tests to get a good risk assessment; the three routine markers already capture the most important information.

The researchers also checked how well this score would hold up in real-world scenarios by using statistical techniques to simulate different patient groups and testing the score's ability to make accurate decisions. The score consistently separated patients into distinct risk groups. When the researchers used the score to help decide who should be monitored closely, they found it could identify more patients who would actually need intensive care without flagging too many healthy patients unnecessarily. This means the score could help hospitals plan better, ensuring that intensive care beds are available for those who truly need them while avoiding unnecessary transfers for patients who can recover safely on a regular ward.

Ultimately, this work offers a practical tool for the operating room. It does not replace the judgment of a surgeon or an anesthesiologist, but it adds a layer of biological insight that was previously missing. By looking at the convergence of clotting, inflammation, and nutrition, the score provides a way to see the patient's body as a whole system rather than just a collection of separate parts. The study concludes that this simple, three-number score is a reliable way to anticipate who will struggle after surgery. It is a reminder that sometimes the most effective tools are not the most complex ones, but rather those that clearly reveal the fundamental state of the human body before it faces the stress of a major operation.